ABVC BioPharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
ABVC BioPharma, Inc. Earnings Date And Information
ABVC BioPharma, Inc. last posted its earnings results on Monday, May 15th, 2023. The company reported $-0.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.5 by $0.1. The company had revenue of 389,276 for the quarter and had revenue of 152,430 for the year. ABVC BioPharma, Inc. has generated $-2 earnings per share over the last year ($-2.43 diluted earnings per share) and currently has a price-to-earnings ratio of -0.77. ABVC BioPharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based on prior year's report dates.
ABVC BioPharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.02 | $389,276 | $389,276 | ||
| 08/14/2024 | Q2 2024 | -$0.09 | $117,142 | $117,142 | ||
| 05/17/2024 | Q1 2024 | -$0.40 | $1,205 | |||
| 03/14/2024 | Q4 2023 | -$0.39 | $2,165 | |||
| 11/15/2023 | Q3 2023 | -$0.82 | $300,000 | $15,884 | ||
| 08/14/2023 | Q2 2023 | -$0.68 | $300,000 | $6,109 | ||
| 05/15/2023 | Q1 2023 | -$0.50 | -$0.02 | 0.48 | $128,272 | |
| 03/31/2023 | Q4 2022 | -$1.90 | -$1.38 | 0.52 | $588,994 | |
| 11/14/2022 | Q3 2022 | -$2.00 | -$1.16 | 0.84 | $26,176 | $42,269 |
| 08/15/2022 | Q2 2022 | -$2.00 | -$0.62 | 1.38 | $25,917 | $312,860 |
| 05/16/2022 | Q1 2022 | -$2.00 | $25,660 | |||
| 03/31/2022 | Q4 2021 | -$0.04 | -$3.10 | -3.06 | $-37,793 | |
| 11/15/2021 | Q3 2021 | -$0.40 | -$0.70 | -0.3 | $113,257 | $98,999 |
| 08/11/2021 | Q2 2021 | -$0.04 | -$0.80 | -0.76 | $263,000 | $31,440 |
| 05/10/2021 | Q1 2021 | -$0.50 | $263,150 | |||
| 03/16/2021 | Q4 2020 | -$0.10 | -$2.50 | -2.4 | $62,193 | |
| 11/17/2020 | Q3 2020 | -$0.90 | $115,553 | |||
| 08/14/2020 | Q2 2020 | -$0.90 | $226,513 | |||
| 06/29/2020 | Q1 2020 | -$0.60 | $78,786 | |||
| 05/15/2020 | Q4 2019 | -$0.60 | $99,962 |
ABVC BioPharma, Inc. Earnings: Frequently Asked Questions
-
When is ABVC BioPharma, Inc.'s earnings date?
ABVC BioPharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 20th, 2024 based off last year's report dates.
-
How can I listen to ABVC BioPharma, Inc.'s earnings conference call?
The conference call for ABVC BioPharma, Inc.'s latest earnings report can be listened to online.
-
How can I read ABVC BioPharma, Inc.'s conference call transcript?
The conference call transcript for ABVC BioPharma, Inc.'s latest earnings report can be read online.
-
How much revenue does ABVC BioPharma, Inc. generate each year?
ABVC BioPharma, Inc. (:ABVC) has a recorded annual revenue of $152,430.
-
How much profit does ABVC BioPharma, Inc. generate each year?
ABVC BioPharma, Inc. (:ABVC) has a recorded net income of $152,430. ABVC BioPharma, Inc. has generated $-2.43 earnings per share over the last four quarters.
-
What is ABVC BioPharma, Inc.'s price-to-earnings ratio?
ABVC BioPharma, Inc. (:ABVC) has a price-to-earnings ratio of -0.77 and price/earnings-to-growth ratio is -0.02.
